NCT05323305

Brief Summary

The study will be designed to compare the analgesic effect of ultrasound-guided pectointercostal fascial plane block versus tansversus thoracic plane block in adult cardiac surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

March 30, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

April 12, 2022

Status Verified

March 1, 2022

Enrollment Period

6 months

First QC Date

March 21, 2022

Last Update Submit

April 5, 2022

Conditions

Keywords

Ultrasound, pectointercostal, Cardiac surgery

Outcome Measures

Primary Outcomes (1)

  • the analgesic effectiveness of the two blocks on midline sternotomy pain,

    Postoperative pain evaluation after extubation will be done using the Visual Analogue Scale (VAS). a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 0 "no pain" and 10 "worst pain."

    from end of surgery till discharge from ICU (96 hours)

Secondary Outcomes (2)

  • pulmonary complications

    from end of surgery till discharge from ICU (96 hours)

  • length of stay in ICU

    average 4 days

Study Arms (2)

Pectointercostal Group (n=30)

ACTIVE COMPARATOR

They will receive ultrasound-guided pectointercostal fascial block after induction of anesthesia with equal dose before extubation in the intensive care.

Procedure: ultrasound guided regional block

Transversus thoracic Group (n=30)

ACTIVE COMPARATOR

They will receive ultrasound-guided ultrasound-guided transversus thoracic plane block after induction of anesthesia with equal dose before extubation in the intensive care.

Procedure: ultrasound guided regional block

Interventions

Bupivacaine injection by the use of ultrasound in the pectointercostal fascial plane in one group and in the trasversus thoracic plane in the other group.

Also known as: ultrasound guided nerve block
Pectointercostal Group (n=30)Transversus thoracic Group (n=30)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient.
  • Elective cardiac surgery.

You may not qualify if:

  • Refusal to participate.
  • Redo or urgent cardiac surgery.
  • Local infection of the skin at the site of needle puncture.
  • Allergy to bupivacaine.
  • Coagulation disorders.
  • Clinically significant liver or kidney disease, heart failure, moderate to severe pulmonary hypertension.
  • when extubation is intentionally planned to be delayed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria University Hospitals

Alexandria, Egypt

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • islam Omar, MD

    Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university

    STUDY CHAIR
  • Ibrahim Ibrahim, MD

    Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university

    PRINCIPAL INVESTIGATOR
  • Moustafa Halwag, MD

    Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university

    STUDY DIRECTOR

Central Study Contacts

Ibrahim Ibrahim, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2022

First Posted

April 12, 2022

Study Start

March 30, 2022

Primary Completion

October 1, 2022

Study Completion

December 1, 2022

Last Updated

April 12, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Immediately after publication No end date
Access Criteria
Any one who wishes to access the data

Locations